Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amarendra Pegu

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Nature|August 15, 2014
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionSung-Youl Ko, Amarendra Pegu, Rebecca S Rudicell, et al.
Structure (London, England : 1993)|July 16, 2022
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerabilityWei Shi, Lingshu Wang, Tongqing Zhou, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Science (New York, N.Y.)|March 24, 2022
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529Tongqing Zhou, Lingshu Wang, John Misasi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Plos Pathogens|April 4, 2019
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopesSean P O'Brien, Adrienne E Swanstrom, Amarendra Pegu, et al.
Science Translational Medicine|April 23, 2025
FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting <i>Plasmodium falciparum</i> circumsporozoite proteinNeville K Kisalu, Lais D Silva Pereira, Jonathan D Herman, et al.
Mabs|February 2, 2023
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang, Jason Gorman, Young D Kwon, et al.
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Nature|August 15, 2014
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionSung-Youl Ko, Amarendra Pegu, Rebecca S Rudicell, et al.
Structure (London, England : 1993)|July 16, 2022
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerabilityWei Shi, Lingshu Wang, Tongqing Zhou, et al.
Nature Communications|January 9, 2020
Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunityMariya B Shapiro, Tracy Cheever, Delphine C Malherbe, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Science (New York, N.Y.)|March 24, 2022
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529Tongqing Zhou, Lingshu Wang, John Misasi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Plos Pathogens|April 4, 2019
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopesSean P O'Brien, Adrienne E Swanstrom, Amarendra Pegu, et al.
Science Translational Medicine|April 23, 2025
FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting <i>Plasmodium falciparum</i> circumsporozoite proteinNeville K Kisalu, Lais D Silva Pereira, Jonathan D Herman, et al.
Mabs|February 2, 2023
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potencyBaoshan Zhang, Jason Gorman, Young D Kwon, et al.
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Pageof 9